Research Overview

Sleep is a fundamental biological process required for memory consolidation, immune function, metabolic regulation, and cellular repair. The American Academy of Sleep Medicine and Sleep Research Society recommend 7–9 hours for adults, yet surveys consistently find 35% of adults sleep less than 7 hours regularly.

Short sleep duration is independently associated with increased risk of obesity (odds ratio 1.55), type 2 diabetes (OR 1.37), hypertension (OR 1.28), and cardiovascular events — making sleep arguably one of the most impactful health behaviors.

A landmark meta-analysis (Riemann et al., 2017) confirmed CBT-I produces superior long-term outcomes compared to pharmacological treatment, with remission rates of 35–50% in chronic insomnia.

Common Causes of Poor Sleep

  • Stress and anxiety: HPA axis activation elevates cortisol, impairing sleep onset and maintenance
  • Poor sleep hygiene: Irregular schedules, light exposure, temperature dysregulation
  • Circadian rhythm disruption: Shift work, travel, excessive evening light
  • Sleep apnea: Affects 26% of adults 30–70; disrupts sleep architecture without awareness
  • Nutrient deficiencies: Magnesium, iron, B12 deficiencies are linked to sleep disturbance
  • Stimulant timing: Caffeine half-life of ~5 hours means afternoon coffee disrupts night sleep
  • Medications: SSRIs, steroids, beta-blockers, diuretics

Types of Sleep Disorders

  • Insomnia disorder: Difficulty falling or staying asleep ≥3 nights/week for ≥3 months; affects ~10–15% of adults
  • Obstructive sleep apnea (OSA): Airway collapse during sleep; strongly associated with cardiovascular disease
  • Restless legs syndrome (RLS): Uncomfortable sensations driving urge to move legs; often linked to iron deficiency
  • Circadian rhythm disorders: Delayed sleep phase, advanced sleep phase, shift work disorder
  • Parasomnias: Sleepwalking, sleep terrors, REM sleep behavior disorder

Evidence-Based Interventions

CBT-I (First-line recommendation — Strong evidence):

  • Sleep restriction therapy: Temporarily limits time in bed to consolidate sleep drive
  • Stimulus control: Reassociates bed with sleep (not wakefulness)
  • Cognitive restructuring: Addresses dysfunctional beliefs about sleep
  • Relaxation techniques: Progressive muscle relaxation, diaphragmatic breathing
  • Sleep hygiene education

Available via apps (Sleepio, Somryst), therapists, and online programs.

Supplement Evidence

  • Magnesium glycinate: Moderate evidence; improves sleep onset and efficiency, particularly in those with suboptimal intake (see full review)
  • Melatonin: Strong evidence for circadian rhythm disorders and jet lag; moderate for primary insomnia (0.5–5mg, 30–60 min before bed)
  • L-theanine: Modest evidence for relaxation and sleep quality without sedation (200mg)
  • Ashwagandha: Moderate evidence for sleep quality in stressed adults (see full review)
  • Valerian root: Mixed evidence; some trials show modest benefit for sleep latency

Sleep Hygiene: Evidence-Based Practices

  • Consistent schedule: Same wake time daily — the most powerful circadian anchor
  • Light exposure: Morning sunlight (10–30 min) advances circadian phase; avoid blue light 1–2h before bed
  • Temperature: Bedroom 65–68°F (18–20°C) optimal for sleep onset; warm bath 1–2h before bed paradoxically helps
  • Caffeine cutoff: No caffeine after 2pm for most adults (individual variation exists)
  • Alcohol: Suppresses REM sleep; avoid within 3h of bedtime
  • Exercise: Regular moderate exercise improves sleep quality; vigorous exercise within 2h of bed may delay onset in some

Frequently Asked Questions

CBT-I (Cognitive Behavioral Therapy for Insomnia) is the first-line, evidence-based treatment for chronic insomnia, producing better long-term outcomes than sleeping pills. It addresses the behavioral and cognitive factors maintaining insomnia. CBT-I is available via therapists, group programs, and digital apps.

The AASM and Sleep Research Society recommend 7–9 hours for adults. Individual variation exists, but consistently sleeping less than 7 hours is associated with significant health risks including metabolic, cardiovascular, and immune consequences.

Supplements do not cure insomnia. Melatonin and magnesium have evidence as adjunctive support — particularly for circadian rhythm disruption and magnesium deficiency — but cannot replace CBT-I or address underlying causes. Chronic insomnia requires a behavioral and sometimes medical approach.

Waking at 3am typically reflects maintenance insomnia, often linked to anxiety, sleep apnea, hormonal fluctuations, alcohol consumption, or sleep pressure issues. It can also reflect cortisol surge (the stress hormone peaks in early morning). CBT-I techniques for sleep maintenance insomnia are the most evidence-based approach.

Melatonin has strong evidence for circadian rhythm disorders (jet lag, shift work, delayed sleep phase) and moderate evidence for sleep onset insomnia. The effective dose is lower than most commercial products — 0.5–1mg is often sufficient; higher doses do not improve effectiveness and may cause next-day grogginess.

Research Summary

Sleep disorders are among the most impactful and modifiable health conditions. CBT-I is the gold-standard treatment; sleep hygiene practices have strong evidence; supplements offer adjunctive support.

  • Evidence strength: Strong (5/5)
  • First-line treatment: CBT-I (behavioral therapy)
  • Best supplement adjunct: Melatonin (circadian), Magnesium (quality)
  • Critical behavior: Consistent wake time daily
  • Most common cause: Anxiety + poor sleep hygiene
⚠️ Medical Disclaimer: This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any supplement or making changes to your health routine.

References

All studies cited are peer-reviewed and publicly accessible. DOI and PubMed links open in a new tab.

  1. 1. Riemann D, Baglioni C, Bassetti C, et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675–700. doi:10.1111/jsr.12594 PMID:28875581
  2. 2. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D (2015). Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 163(3), 191–204. doi:10.7326/M14-2841 PMID:26054060
  3. 3. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA (2010). Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep, 33(5), 585–592. doi:10.1093/sleep/33.5.585 PMID:20469800
  4. 4. Watson NF, Badr MS, Belenky G, et al. (2015). Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep, 38(6), 843–844. doi:10.5665/sleep.4716 PMID:26039963
  5. 5. Ferracioli-Oda E, Qawasmi A, Bloch MH (2013). Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLOS ONE, 8(5), e63773. doi:10.1371/journal.pone.0063773 PMID:23691095